Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

Flufenamic acid activates KCNMA1. 1 / 1

| 1

➶

reach

"In contrast to KCa2 and KCa3.1, the phylogenetically distantly related large-conductance voltage gated and non-calmodulin-regulated KCa1.1 in human U251 glioblastoma cells was not blocked by 13b (XREF_SUPPLEMENTARY) while flufenamic acid at 10 microM was found to potentiate KCa1.1 by 2.7-fold similar to a previous report XREF_BIBR and caffeic acid at 10 microM had no blocking or activating effects (XREF_SUPPLEMENTARY)."

23516517

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...